Reneuron Group plc

Company Information

Address:

10 Nugent Road
Surrey Research Park
Guildford
GU2 7AF

Tel:

+44 (0)1483 302560

Fax:

+44 (0)1483 534864

E-Mail:

info@reneuron.com

Secretary:

Michael Hunt

Registrar:

Company Overview

They are a leading, clinical-stage stem cell business. They have used their unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered "off-the-shelf" to any eligible patient without the need for additional drug treatments. Their lead therapeutic candidate is our ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. This treatment is currently in clinical development. They are also developing stem cell therapies for other conditions such as critical limb ischaemia, a serious and common side effect of diabetes, and blindness-causing diseases of the retina.

Annual Reports

Description Report Date Published
Annual Report 201331-03-201309-08-2013
Annual Report 201231-03-201209-07-2012
Annual Report 201131-03-201122-07-2011
Annual Report 201031-03-201030-07-2010
Annual Report 200931-03-200923-07-2009
Annual Report 200831-03-200808-07-2008
Annual Report 200731-03-200706-07-2007
Annual Report 200631-03-200614-08-2006

Interim Reports

Description Report Date Published
Interim Report 201230-09-201204-12-2012
Interim Report 201030-09-201013-12-2010
Interim Report 200930-09-200926-11-2009
Interim Report 200830-09-200828-11-2008
Interim Report 200730-09-200703-12-2007
Interim Report 200630-09-200606-12-2006
Interim Report 200530-09-200530-11-2005

Dividend Histroy

Type Dividend Payment Date
Nil0.000001-01-1970
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #